Babal Khan Jha

22PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 29, 2026
MCL1 may not mediate chemoresistance in cancer cells.

|Aug 20, 2026
FLT3-ITD signals for CEBPA and p53 proteolysis by the ubiquitin-proteosome pathway.

|Dec 10, 2024
JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms.

Brittany L Stewart, Hetty E Carraway, Adriana L Alvarez

|Feb 28, 2024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Yasuo Kubota, Xiaorong Gu, Laila Terkawi

|Jul 29, 2023
Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication.

Abhishek Asthana, Angela Corona, Woo-Jin Shin

|Sep 09, 2022
Multiple Myeloma Therapy: Emerging Trends and Challenges.

Danai Dima, Dongxu Jiang, Divya Jyoti Singh

Pageof 4

Frequent Collaborators

7 joint publications

Yihong Guan

4 joint publications

Tomas Radivoyevitch

4 joint publications

Carmelo Gurnari

4 joint publications

Yogen Saunthararajah